Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis

@article{JadidiNiaragh2010HistamineAH,
  title={Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis},
  author={Farhad Jadidi-Niaragh and Abbas Mirshafiey},
  journal={Neuropharmacology},
  year={2010},
  volume={59},
  pages={180-189}
}
Multiple sclerosis (MS) is an autoimmune disease associated with chronic inflammatory demyelination of the central nervous system (CNS). Due to disease complexity and heterogeneity, its pathogenesis remains unknown and despite extensive studies, specific effective treatments have not yet been developed. The factors behind the initiation of the inflammatory reactions in CNS have not been identified until now. MS is considered as a complex disease depending on genetic as well as environmental… Expand
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis
TLDR
Evidence of the complex and controversial role of histamine in the pathogenesis of MS and EAE is reviewed and the therapeutic potential of histaminergic ligands in the treatment of autoimmune diseases is evaluated. Expand
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis
TLDR
It has been suggested that promotion of adenosinergic system may be an important factor in MS pathophysiology and considered as promising therapeutic target for this disease. Expand
Histamine H4 Receptor Optimizes T Regulatory Cell Frequency and Facilitates Anti-Inflammatory Responses within the Central Nervous System
TLDR
It is shown that, compared with wild-type mice, animals with a disrupted Hrh4 (H4RKO) develop more severe myelin oligodendrocyte glycoprotein (MOG)35\x{2013}55-induced experimental allergic encephalomyelitis and the lack of H4R leads to an impairment of an anti-inflammatory response. Expand
Serum levels of histamine and diamine oxidase in multiple sclerosis.
TLDR
The research team found significant low levels of histamine and diamine oxidase in RRMS patients; however the pathogenesis of this issue was unclear. Expand
Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances
TLDR
The most recent developments showing the involvement of type 2 inflammatory components in CNS autoimmunity are summarised and possible lines of further investigation are discussed. Expand
The Role of Autoantibodies in Diagnosis of Multiple Sclerosis
TLDR
The most significant autoantibodies which could be used as biomarkers for diagnosis, prognosis and treatment in MS are discussed and the hope is that biomarkers speed up the MS monitoring. Expand
Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells
TLDR
The treatment of immethridine was used to treat Experimental autoimmune encephalomyelitis (EAE) and its therapeutic effect was evaluated, showing that the treatment ofimmethridines could alleviate EAE. Expand
New kid on the block: does histamine get along with inflammation in amyotrophic lateral sclerosis?
Results from amyotrophic lateral sclerosis (ALS) patients and pre-clinical studies strongly suggest that systemic and CNS-intrinsic immune activation plays a central role in ALS pathogenesis.Expand
Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis
TLDR
Possible roles of gastric acid inhibitors on immunopathogenic mechanisms associated with multiple sclerosis are reviewed. Expand
Elevated CSF histamine levels in multiple sclerosis patients
TLDR
CSF histamine levels in MS patient samples were significantly higher than in controls and increased with age, suggesting histamine may be an important factor for both the initiation and maintenance of chronic inflammatory diseases of the central nervous system. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 195 REFERENCES
Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS
TLDR
It is reported that, compared with wild-type animals, mice with a disrupted HA H3 receptor (H3RKO) develop more severe disease and neuroinflammation and it is shown that this effect is associated with dysregulation of blood–brain barrier permeability and increased expression of MIP-2, IP-10, and CXCR3 by peripheral T cells. Expand
The histamine H4 receptor in autoimmune disease
TLDR
H4R antagonists have been shown to have anti-inflammatory properties and efficacy in a number of disease models, such as those for asthma and colitis in vivo and may be useful in treating autoimmune diseases in addition to allergy. Expand
The role of histamine H4 receptor in immune and inflammatory disorders
TLDR
The available data strongly point to the H4 receptor as a novel target for the pharmacological modulation of histamine‐transferred immune signals and offer an optimistic perspective for the therapeutic exploitation of this promising new drug target in inflammatory disorders. Expand
Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination
TLDR
It is demonstrated that, in the animal model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE), mediated by T helper 1 (Th1) T cells, histamine receptor 1 and 2 (H1R and H2R) are present on inflammatory cells in brain lesions. Expand
Activation of histamine H2 receptors ameliorates experimental allergic encephalomyelitis
TLDR
Dimaprit treatment significantly reduced clinical signs compared to vehicle in both C57BL/6 and iNOS deficient EAE mice and significantly reduced CNS staining for lectin-positive macrophages and decreased extravasated albumin staining, an indicator of blood–brain barrier leakage. Expand
A Key Regulatory Role for Histamine in Experimental Autoimmune Encephalomyelitis: Disease Exacerbation in Histidine Decarboxylase-Deficient Mice1
TLDR
Endogenous histamine appears to regulate importantly the autoimmune response against myelin and the expression of EAE, in this model, and to limit immune damage to the CNS. Expand
Corticotropin-releasing hormone and the blood-brain-barrier.
TLDR
Acute stress shortens the time of onset of experimental alleric encephalomyelitis that does not develop in W/W mast cell deficient or CRH -/- mice, and brain mast cell inhibition and CRHR antagonists offer novel therapeutic possibilities. Expand
Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation.
TLDR
It is indicated that brain mast cells are associated with EAE development and that inhibition of their activation correlates positively with the clinical outcome, and hydroxyzine treatment inhibited the progression and severity of EAE. Expand
Histamine in health and disease.
TLDR
The realization that first-generation antihistamines often had mixed pharmacological properties and crossed the blood-brain barrier led to the development of the second-generation drugs, which are more selective for H1-receptors, have less access to the central nervous system, and, therefore, a more favorable benefit-to-risk ratio (therapeutic index). Expand
A Pilot, Open Label, Clinical Trial Using Hydroxyzine in Multiple Sclerosis
TLDR
Hydxyzine could be used as an adjuvant in MS, but the small number of patients enrolled and the short duration of the study precludes any definitive conclusions. Expand
...
1
2
3
4
5
...